144
G.A. Mohamed / Phytochemistry Letters 16 (2016) 141–145
and C, favoring the interaction of the flavonoid with the enzymatic
site receptor (Lattig et al., 2007). Kim et al. (2004) reported that the
presence of hydroxyl groups at C-5 and C-7 (ring A) and C-3‘ and C-
4‘ (ring B) positions is an important feature for the anti-
inflammatory action. However, their glycosylation reduces the
activity (Kim et al., 2004).
(6.7 mg, yellow powder) and 3 (11.5 mg, yellow amorphous
powder). Sub-fraction TME-7 (108.9 mg) was subjected to silica
gel column (50 g ꢃ 50 ꢃ 2 cm) using CHCl3:MeOH gradient to get
impure 4 and 5. Their purification was achieved using RP18 column
eluting with MeOH:H2O gradient to give 4 (5.6 mg, yellow
amorphous powder) and 5 (13.1 mg, yellow amorphous powder).
The other sub-fractions were retained for further investigation.
3. Experimental
3.4. Spectral data
3.1. General experimental procedures
3.4.1. Quercetagetin-8-hydroxy-3,6,40-trimethy ether (1)
Yellow amorphous powder (4.2 mg); UV lmax MeOH (nm): 352,
262; NaOCH3: 363, 301 sh, 267; A1C13: 412, 302; +HC1: 370, 272;
NaOAc: 364, 296; +H3BO3: 376, 294; IR (KBr) nmax: 3405, 2989,
1658, 1608, 1056 cmꢀ1; NMR see Table 1; HRESIMS m/z: 377.0879
(calcd for C18H17O9, [M + H]+, 377.0873).
Optical rotation was measured on a JASCO digital polarimeter.
Ultraviolet (UV) spectra were measured on a Hitachi 300 spectro-
photometer. The IR spectra were measured on a Shimadzu
Infrared-400 spectrophotometer (Kyoto, Japan). ESIMS spectra
were obtained with a LCQ DECA mass spectrometer (ThermoFin-
nigan, Bremen, Germany) coupled to an Agilent 1100HPLC system
equipped with a photodiode array detector. HRESIMS was recorded
on LTQ Orbitrap mass spectrometer (ThermoFinnigan, Bremen,
Germany). 1D and 2D NMR spectra were recorded on Bruker
Avance DRX 500 MHz spectrometer. For column chromatography,
silica gel (0.063–0.200 mm, Merck, Darmstadt, Germany), Sepha-
dex LH-20 (0.25–0.1 mm, Sigma-Aldrich), and RP18 (0.04–
0.063 mm Merck, Darmstadt, Germany) were used. Pre-coated
silica gel 60 F254 plates (0.2 mm, Merck, Darmstadt, Germany) were
used for thin-layer chromatography. Six mL standard extraction
3.4.2. Quercetin-3,6-dimethyl ether (2)
Yellow amorphous powder (6.7 mg); 1H NMR (500 MHz, DMSO-
d6): dH 6.52 (1H, s, H-8), 7.67 (1H, d, J = 1.5 Hz, H-20), 6.88 (1H, d,
J = 8.5 Hz, H-50), 7.55 (1H, dd, J = 8.5, 1.5 Hz, H-60), 3.96 (3H, s, 3-
OCH3), 3.76 (3H, s, 3-OCH3),12.58 (1H, s, 5-OH),10.89 (1H, s, 7-OH),
9.34 (1H, s, 30-OH), 9.63 (1H, s, 4-OH); 13C NMR (125 MHz, DMSO-
d6): dC 147.7 (C-2), 135.4 (C-3), 176.0 (C-4), 151.7 (C-5), 130.8 (C-6),
157.2 (C-7), 93.6 (C-8), 151.3 (C-9), 103.3 (C-10), 121.9 (C-10), 115.0
(C-20), 146.9 (C-30), 145.0 (C-40), 115.5 (C-50), 120.0 (C-60), 60.0 (3-
OCH3), 62.9 (6-OCH3); HRESIMS m/z: 347.0762 (calcd for C17H15O8,
[M + H]+, 347.0767).
tube (RP18, 40–63 mm, Merck, Darmstadt, Germany) was used for
compounds purification. The compounds were detected by UV
absorption at lmax 255 and 366 nm, exposure to NH3 vapor
followed by spraying with p-anisaldehyde:H2SO4 reagent and
heating at 110 ꢂC for 1–2 min. Linoleic acid, 5-lipoxygenase kits,
indomethacin, 2,20-diphenylpicrylhydrazyl, and propyl gallate
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
3.4.3. Quercetin-3-methy ether (3)
Yellow amorphous powder (11.5 mg); 1H NMR (500 MHz,
DMSO-d6): dH 6.20 (1H, brs, H-6), 6.44 (1H, brs, H-8), 7.68 (1H,
brs, H-20), 6.89 (1H, d, J = 8.5 Hz, H-50), 7.54 (1H, brd, J = 8.5 Hz, H-60),
3.76 (3H, s, 3-OCH3), 12.49 (1H, s, 5-OH), 10.89 (1H, s, 7-OH), 9.37
(1H, s, 30-OH), 9.66 (1H, s, 40-OH); 13C NMR (125 MHz, DMSO-d6):
dC 156.1 (C-2), 135.7 (C-3), 175.8 (C-4), 160.6 (C-5), 98.2 (C-6), 163.9
(C-7), 93.3 (C-8), 156.1 (C-9), 102.9 (C-10), 121.9 (C-10), 115.0 (C-20),
147.7 (C-30), 145.0 (C-40), 115.6 (C50), 119.9 (C60), 59.9 (3-OCH3);
HRESIMS m/z: 317.0668 (calcd for C16H13O7, [M + H]+, 317.0661).
3.2. Plant material
The plant sample was collected in March 2014 from Al-Baha city,
Saudi Arabia. The plant was kindly identified by a taxonomist at the
Department of Natural products and Alternative Medicine, King
Abdulaziz University, Saudi Arabia, in addition to its morphological
featuresandthelibrarydatabase(Collenette,1999).Itwas confirmed
by Dr. Nahed Morad, Faculty of Science, King Abdulaziz University,
Saudi Arabia. Avoucher specimen (TM-11-2014) was archived at the
Department of Natural Products and Alternative Medicine herbari-
um, King Abdulaziz University, Saudi Arabia.
3.4.4. Quercetagetin-8-hydroxy-3-methoxy-6-O-
b-D-
glucopyranoside (4)
Yellow amorphous powder (5.6 mg); [a]D
25 + 59.08 (c 0.5,
MeOH); UV lmax MeOH (nm): 348, 264; NaOCH3: 402, 274;
A1C13: 416, 308; +HC1: 377, 280; NaOAc: 367, 291; +H3B03: 388,
295; IR (KBr) nmax: 3436, 3989, 1647, 1052 cmꢀ1; NMR see Table 1;
HRESIMS m/z: 511.1091 (calcd for C22H23O14, [M + H]+, 511.1088).
3.3. Extraction and isolation
The air-dried powdered aerial parts (0.9 kg) were macerated
with MeOH (2 ꢃ 3 L). The total methanolic extract was concentrat-
ed under vacuum (22.6 g). The later was mixed with 100 mL
distilled water and fractionated successively between n-hexane
(3 ꢃ 500 mL), EtOAc (3 ꢃ 500 mL), and n-BuOH (3 ꢃ 500 mL). Each
fraction was concentrated to give n-hexane (3.7 g), EtOAc (2.3 g), n-
BuOH (2.1 g), and aqueous (11.2 g) fractions. The EtOAc fraction
(2.3 g) was chromatographed over a Sephadex LH-20 column
(100 g ꢃ 50 ꢃ 3 cm) using MeOH as an eluent to obtain nine sub-
fractions: TME-1 to TME-9. Sub-fraction TME-2 (71.2 mg) was
chromatographed on silica gel column (40 g ꢃ 50 ꢃ 2 cm) and
eluted with CHCl3:MeOH gradient to give impure 1. Purification of
1 was carried out on reversed phase silica gel extraction tube using
H2O with gradual increase of acetonitrile to yield 1 (4.2 mg, yellow
amorphous powder). Silica gel column (50 g ꢃ 50 ꢃ 2 cm) of sub-
fraction TME-4 (115.4 mg) using CHCl3:MeOH gradient elution
gave impure 2 and 3 which were purified on reversed phase silica
gel extraction tube using H2O:acetonitrile gradient to yield 2
3.4.5. Quercetagetin-6-glucose (5)
Yellow amorphous powder (13.1 mg); 1H NMR (500 MHz,
DMSO-d6): dH 6.89 (1H, s, H-8), 7.72 (1H, brs, H-20), 6.94 (1H, d,
J = 8.5 Hz, H-50), 7.54 (1H, brd, J = 8.5 Hz, H-60), 5.02 (1H, d, J = 7.0 Hz,
H-10), 3.21-5.44 (m, sugar protons), 12.24 (1H, s, 5-OH), 9.68 (1H, s,
7-OH), 9.33 (1H, s, 30-OH), 9.39 (1H, s, 40-OH), 8.48 (1H, s, 3-OH);
13C NMR (125 MHz, DMSO-d6): dC 148.1 (C-2), 135.6 (C-3), 176.1 (C-
4), 145.3 (C-5), 129.6 (C-6), 151.5 (C-7), 93.5 (C-8), 147.5 (C-9), 105.1
(C-10), 122.0 (C-10), 115.3 (C-20), 145.0 (C-30), 147.7 (C-40), 115.5 (C-
50), 119.9 (C-60), 100.8 (C-100), 73.1 (C-200), 75.7 (C-300), 69.6 (C400),
77.2 (C-500), 60.6 (C-600); HRESIMS m/z: 481.0987 (calcd for
C
21H21O13, [M + H]+, 481.0982).
3.5. Acid hydrolysis
A solution of the isolated glycoside 4 (3 mg in 5 mL MeOH) was
treated with 3% H2SO4 (1.5 mL) and heated at 100 ꢂC for 1 h. The
aglycone was extracted with EtOAc, concentrated under reduced